Tivic Health™ Systems, a bioelectronic medical device company that treats chronic conditions, today announced an $8 million Series Seed investment from Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital, Skylight Investments, a physician network and individual investors. The company has raised funds in a series of tranches, the most recent of which closed last week.
An Over-the-Counter Device that Treats Sinus Pain from Allergic Rhinitis & Hay Fever SAN FRANCISCO, July 1, 2019 /PRNewswire/ — Tivic Health’s Indiegogo campaign for ClearUP™ Sinus Pain Relief launched last week and reached 100 percent of its fundraising goal in 24 hours and attracted 360 buyers. ClearUP is a small hand-held device that uses […]
San Francisco, June 19, 2019 – The Silicon Valley Business Journal today named Tivic Health Systems’ Chief Scientific Officer, Blake Gurfein, PhD to their annual 40 Under 40 Awards which honors 40 business executives, entrepreneurs, nonprofit leaders and community officials who have made an indelible mark before they reached the age of 40. This year’s […]
San Francisco, May 28, 2019 – Tivic HealthTM Systems today announced the expansion of its executive team with the appointments of Subinoy Das, MD as Chief Medical Officer and Michael Nketiah as Vice President of Quality and Regulatory Affairs. Earlier this year, Tivic Health received 510(k) clearance from the FDA for ClearUPTM Sinus Pain Relief, […]
San Francisco, April 17, 2019 – Allergy season is here with a vengeance and according to the American College of Allergy, Asthma and Immunology over 40 million Americans suffer from some form of allergic rhinitis (hay fever) and are feeling the effects of spring pollen, mold and other environmental allergens. Seasonal allergic rhinitis occurs at […]
SAN FRANCISCO, CA, JANUARY 17, 2019 – Tivic Health’sTM first product, ClearUPTM Sinus Pain Relief, received two awards at CES 2019: Best of CES from Gear Diary and Top Picks of CES from Techlicious. Introduced last week at CES, ClearUP uses gentle microcurrent waveforms to provide sinus pain relief to the 40 to 60 million […]
SAN FRANCISCO, CA, JANUARY 3, 2019 – Tivic Health Systems Inc. today announced that ClearUP Sinus Pain Relief, a first-in-class bioelectronic treatment for sinus pain due to allergic rhinitis (hay fever), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). ClearUP is an over-the-counter (OTC) device that provides consumers with a simple, […]
CLEARUP TREATS COMMON SINUS PAIN FROM ALLERGIC RHINITIS AT CES 2019, EUREKA PARK, BOOTH 53355 Las Vegas, December 17, 2019 – Tivic Health™, a bioelectronic device company, will introduce ClearUP™ Sinus Pain Relief – the first bioelectronic treatment for sinus pain at CES 2019. ClearUP is a handheld device that offers a new way to […]
Top 5 Finalist for 2018 Start Up of the Year Award from (CTA), Innovate Celebrate Event Runner Up for Best Clinical Manuscript at the American Rhinologic Society (ARS) Annual Meeting MENLO PARK, Calif., October 25, 2018–(BUSINESS WIRE)–Tivic Health Systems, Inc. has been selected as one of the TOP 5 FINALISTS at last week’s Startup of the Year […]
MENLO PARK, Calif., October 29, 2018–(BUSINESS WIRE)–According to Scientific American, electroceuticals, a branch of neurotechnology, is one of the top 10 emerging technologies of 2018. One of the prominent neurotechnology organizations, Neurotech Reports, held their annual Neurotech Leaders Forum recently in San Francisco, California. During the event, Tivic Health Systems was awarded the Gold Electrode Award for Most […]
Stay Informed!
Join our mailing list for Tivic news, offers and more